Loading...
Erlotinib
India Pharmaceutical Trade Intelligence
Who Supplies Erlotinib to India from MALAYSIA
India's erlotinib imports from MALAYSIA total $351 across 3 shipments from 2 foreign suppliers. NOVUGEN ONCOLOGY SDN BHD leads with $254 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CLIANTHA RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for erlotinib — a concentrated sourcing relationship with select suppliers from MALAYSIA.
Top foreign suppliers (MALAYSIA) — Ranked by import value
NOVUGEN ONCOLOGY SDN BHD is the leading Erlotinib supplier from MALAYSIA to India, with import value of $254 across 2 shipments. The top 5 suppliers — NOVUGEN ONCOLOGY SDN BHD, NOVUGEN ONCOLOGY SDN. BHD,. — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (MALAYSIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVUGEN ONCOLOGY SDN BHD | $254 | 2 | 72.4% |
| 2 | NOVUGEN ONCOLOGY SDN. BHD,. | $97 | 1 | 27.6% |
Showing top 2 of 2 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from MALAYSIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CLIANTHA RESEARCH LIMITED | $254 | 2 | 72.4% |
| 2 | ACCUTEST RESEARCH LABORATORIES I PVT LTD | $97 | 1 | 27.6% |
Import Statistics
- Import Value
- $351
- Shipments
- 3
- Foreign Suppliers
- 2
- Indian Buyers
- 2
- Avg. Shipment
- $117
Other Erlotinib Import Origins
Frequently Asked Questions — Erlotinib Imports from MALAYSIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Erlotinib suppliers from MALAYSIA to India?
The top Erlotinib suppliers from MALAYSIA to India include NOVUGEN ONCOLOGY SDN BHD, NOVUGEN ONCOLOGY SDN. BHD,.. The leading supplier is NOVUGEN ONCOLOGY SDN BHD with import value of $254 USD across 2 shipments. India imported Erlotinib worth $351 USD from MALAYSIA in total across 3 shipments.
QHow much Erlotinib does India import from MALAYSIA?
India imported Erlotinib worth $351 USD from MALAYSIA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Erlotinib from MALAYSIA?
The main Indian buyers of Erlotinib sourced from MALAYSIA include CLIANTHA RESEARCH LIMITED, ACCUTEST RESEARCH LABORATORIES I PVT LTD. The largest buyer is CLIANTHA RESEARCH LIMITED with $254 in imports across 2 shipments.
QWhat is the total value of Erlotinib imports from MALAYSIA to India?
The total value of Erlotinib imports from MALAYSIA to India is $351 USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: MALAYSIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Erlotinib.
- 2.Supplier/Buyer Matching: 2 foreign suppliers from MALAYSIA and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $351 aggregated from 3 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists